Mydecine

Mindleap Psychedelics & Wellness App Connecting Where Other Telehealth Brands Miss The Mark

Oct 20, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of October 4

Oct 9, 2021

Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing

Oct 7, 2021

Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr.…

Oct 5, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of September 27

Oct 2, 2021

Mydecine Completes Spin-Out of U.S. Cannabis Assets

Oct 1, 2021

Changing The Public’s View On Psychedelic Therapeutics With Mydecine Innovation’s Dr. Jetly

Oct 1, 2021

Mydecine Innovations CMO Talks MYCO-001 Clinicals & Future Of Psychedelic Therapeutics

Sep 30, 2021

Second Generation Psychedelics: What Are They, And Do We Need Them?

Sep 25, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of September 20

Sep 25, 2021